1. Diagnostic accuracy of large-core needle biopsy for nonpalpable breast disease: a meta-analysis
- Author
-
van Vroonhoven Tj, Helena M. Verkooijen, Erik Buskens, Borel Rinkes Ih, Mali Wp, V. C. M. Koot, and P. H. M. Peeters
- Subjects
Breast biopsy ,Quality Control ,Cancer Research ,medicine.medical_specialty ,Mammary gland ,non-palpable breast disease ,Malignancy ,Sensitivity and Specificity ,Breast Diseases ,Breast cancer ,Predictive Value of Tests ,Biopsy ,medicine ,Carcinoma ,Humans ,Randomized Controlled Trials as Topic ,medicine.diagnostic_test ,business.industry ,Biopsy, Needle ,Regular Article ,medicine.disease ,Surgery ,meta-analysis ,medicine.anatomical_structure ,Oncology ,Predictive value of tests ,large-core needle biopsy ,Female ,diagnostic accuracy ,Breast disease ,business - Abstract
For the evaluation of non-palpable lesions of the breast, image-guided large-core needle biopsies are increasingly replacing needle-localized open breast biopsies. In this study, the diagnostic accuracy of this minimally invasive technique was evaluated by reviewing the available literature. Five cohort studies were included in a meta-analysis. Sensitivity rate, histological agreement between needle biopsy and subsequent surgery or long-term mammographic follow-up and clinical consequences for different disease prevalences were assessed. The sensitivity rate of large-core needle biopsy for the diagnosis of breast cancer was high (97%). The reclassified agreement rate between core biopsy and subsequent surgical biopsy or long-term mammographic follow-up was also high (94%). In case of 20% breast cancer prevalence among women referred after screening (as in the US), the risk of breast cancer despite benign large-core needle biopsy result is less than 1%. In European countries, however, prevalence of breast cancer among referred women is 60–70%. This would result in a risk of breast cancer despite benign large-core needle biopsy result of 4–6%. The results of this meta-analysis indicate that the image guided large-core needle biopsy is a promising alternative for the needle localized breast biopsy. However, additional research is needed to explore the limiting factors of the technique. Without such detailed knowledge, a benign histological diagnosis on large-core needle biopsy in countries with high prevalence of malignancy among referred women should be interpreted with caution. © 2000 Cancer Research Campaign
- Published
- 2000